{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:17:52Z","timestamp":1773004672924,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2018JY0158"],"award-info":[{"award-number":["2018JY0158"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.intimp.2018.12.004","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T01:13:56Z","timestamp":1544231636000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Resveratrol attenuates the MSU crystal-induced inflammatory response through the inhibition of TAK1 activity"],"prefix":"10.1016","volume":"67","author":[{"given":"Hongmei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochun","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2018.12.004_bb0005","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI29404","article-title":"Gout: new insights into an old disease","volume":"116","author":"Martinon","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.intimp.2018.12.004_bb0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.intimp.2018.12.004_bb0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2018.12.004_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.it.2013.03.007","article-title":"Cell type-specific function of TAK1 in innate immune signaling","volume":"34","author":"Ajibade","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2018.12.004_bb0025","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1074\/jbc.M407537200","article-title":"Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2","volume":"280","author":"Singhirunnusorn","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2018.12.004_bb0030","doi-asserted-by":"crossref","first-page":"25753","DOI":"10.1074\/jbc.M109.093468","article-title":"Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process","volume":"285","author":"Scholz","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7081","key":"10.1016\/j.intimp.2018.12.004_bb0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2018.12.004_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.immuni.2011.12.010","article-title":"TAK1 negatively regulates NF-\u03baB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils","volume":"36","author":"Ajibade","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2018.12.004_bb0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tips.2012.06.007","article-title":"Targeting of TAK1 ininflammatory disorders and cancer","volume":"33","author":"Sakurai","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2018.12.004_bb0050","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/intimm\/dxl082","article-title":"TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells","volume":"18","author":"Sato","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2018.12.004_bb0055","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood-2010-02-269605","article-title":"RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells","volume":"116","author":"Courties","year":"2010","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.intimp.2018.12.004_bb0060","first-page":"18485","article-title":"TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis","volume":"278","author":"Li","year":"2017","journal-title":"Cell Discov."},{"key":"10.1016\/j.intimp.2018.12.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2018.12.004_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10847-006-9047-8","article-title":"Host\u2013guest interaction study of resveratrol with natural and modified cyclodextrins","volume":"55","author":"Bertacche","year":"2006","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.intimp.2018.12.004_bb0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.foodchem.2008.04.042","article-title":"Complexation of resveratrol with cyclodextrins: solubility and antioxidant activity","volume":"113","author":"Lu","year":"2009","journal-title":"Food Chem."},{"key":"10.1016\/j.intimp.2018.12.004_bb0080","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar2930","article-title":"High-density lipoproteins down-regulate CCL2 production in human fibroblast like synoviocytes stimulated by urate crystals","volume":"12","author":"Scanu","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2018.12.004_bb0085","first-page":"1359","article-title":"Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis","volume":"43","author":"Post","year":"2002","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2018.12.004_bb0090","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1172\/JCI98446","article-title":"ASK1\/2 signaling promote inflammation in a mouse model of neutrophilic dermatosis","volume":"128","author":"Tartey","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2018.12.004_bb0095","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s10495-013-0864-0","article-title":"TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy","volume":"18","author":"Fan","year":"2013","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.intimp.2018.12.004_bb0100","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10067-014-2836-3","article-title":"The effect of resveratrol on the recurrent attacks of gouty arthritis","volume":"35","author":"Chen","year":"2016","journal-title":"Clin. Rheumatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918308142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918308142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:12:09Z","timestamp":1761585129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918308142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"alternative-id":["S1567576918308142"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.004","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol attenuates the MSU crystal-induced inflammatory response through the inhibition of TAK1 activity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}